The responses to adenosine were studied on isolated, methacholine-precontracted tracheal strips of guinea pigs in the course of long-term caffeine or solvent treatment. Guinea pigs were fed caffeine for 10 weeks (average serum caffeine concentration: 39.1 ± 3.9 µM). In epithelium-intact tracheal preparations (EITPs), sensititization to adenosine-induced relaxation (AIR) developed. It attained a maximum in week 1 of caffeine treatment, and then its level diminished and disappeared completely by weeks 4 -6. In epithelium-denuded tracheal preparations (EDTPs), an increase in the sensitivity to adenosine was observed from week 1 to week 10 (a 4 -6-fold reduction in EC 50 ). Use of a coaxial bioassay system confirmed the role of epithelium in this process. The enhancement of the AIR of the EITPs was not modified by inhibitors of cyclooxygenase and lipoxygenase. Following depletion of the neuropeptides by acute capsaicin pretreatment, the AIR of the EITPs was strongly enhanced after caffeine treatment for 6 weeks. In chronically caffeine-treated EITPs, the inhibition of neutral endopeptidase led to dramatic reduction of the AIR. On the basis of the results by inhibiting nitric oxide synthase, it can be supposed that nitric oxide released from EITPs of long-lasting caffeine-treated animals operated as a constrictor agent. Our results show that chronic caffeine treatment gives rise to an initial sensitization to adenosine of the EITPs, this being followed by the development of a specific adaptive process in the epithelial cells, which counterbalances the increased tracheal sensitivity to adenosine.
Introduction
It has long been recognized that receptors are subject to many regulatory controls. Thus, the continuous stimulation of cells with agonists or antagonists results in a state of desensitization or supersensitivity, respectively. Long-term regulation generally occurs through a decrease or increase in receptor expression. Endogenous adenosine is an important mediator in both the central nervous system and the peripheral tissues, the receptors of which can be regulated by the continuous presence of adenosine-receptor agonists or antagonists. Methylxanthines, such as theophylline and caffeine, are conventional non-specific antagonists on the A 1 , A 2A , and A 2B adenosine receptors. The chronic effects of caffeine in the central nervous system have been extensively studied (1, 2) , and it has been suggested that this methylxanthine does not uniformly influence all subtypes of adenosine receptors in the various brain regions. A large body of evidence indicates that the central A 1 receptors are upregulated, whereas the number and function of the A 2A receptors remain unaffected after chronic caffeine exposure, but the results are controversial (3) . The influence of long-term exposure to caffeine has been analyzed in only a few peripheral tissues (e.g., platelets and fat cells); chronic caffeine ingestion proved to alter the adenosine-mediated responses in some but not all peripheral tissues (4 -7) .
The respiratory tract is an important target of various methylxanthines, which are conventional bronchodilator agents used to treat bronchial asthma, and ingredients of widely consumed beverages, for example, coffee and tea. In spite of the fact that pulmonary adenosine receptors play important roles in both the physiological regulation of bronchial functions and the pathomechanism of bronchial asthma (8) , no studies have been published in which the effects of the continuous administration of methylxanthines on adenosine-induced bronchial responses have been analyzed. In this paper, we report that the long-lasting treatment of guinea pigs with relatively high doses of caffeine modulates the adenosine-induced tracheal relaxation in an epitheliumdependent manner. The present findings permit the supposition that following sensitization of the tracheal adenosine receptors, the epithelial cells produce contracting substances, the actions of which may mask the hyper-reactivity of the smooth muscle to adenosine. Some of the findings of this study were previously presented at the Annual Congress of European Respiratory Society, in Glasgow, in 2004 (9) .
Materials and Methods
All the procedures used in this study had been approved and were performed in accordance with the guidelines of the Animal Care and Use Committee of the University of Debrecen and conform to the European Community guiding principles for the care and use of laboratory animals.
Experimental animals and treatments
Male Hartley guinea pigs weighing 420 -530 g were assigned randomly to the control and caffeine-treatment groups. The animals in both groups were housed in individual cages with free access to food and water. The caffeine-treated animals were provided ad libitum with drinking water that contained caffeine (600 mg / l) and sucrose (20 g / l), the latter added to offset the bitter taste of the caffeine. The control guinea pigs received only sucrose (20 g / l) in their drinking water, similarly ad libitum. For 24 h before sacrificing, the animals in the treated group also received only sucrose instead of caffeine + sucrose. In a separate groups of guinea pigs (n = 38), the serum caffeine levels were monitored at different times during caffeine treatment.
Determination of caffeine in serum
Serum levels of caffeine were determined via HPLC as follows: 0.5 ml of serum was taken, 2 ml of methanol was added, and the mixture was incubated at room temperature for 30 min. Following this, the sample was centrifuged at 100 × g for 10 min. The supernatant was removed and dried under a continuous nitrogen flow at room temperature. The dry residue was dissolved in 0.5 ml methanol, and the solution was diluted with 0.5 ml redistilled water, filtered, and injected into a CM 4000 HPLC system (Milton Roy, Riviera Beach, FL, USA) equipped with a UV 440 detector (Waters, Milford, MA, USA) at 254 nm. Samples were chromatographed on a Spherisorb C-18 (ODS2) column (5 µM, 4.6 mm × 250 mm; Waters), using a mobile phase of methanol:water (50:50). The flow rate was 1 ml/ min, the retention time was 4.5 min, and the temperature was 35°C.
Tissue preparation
The guinea pigs were anesthetized with sodium pentobarbitone (50 mg / kg, i.p.). The chest was then opened and the trachea was excised, cleaned of adhering fat and connective tissue, and opened by cutting longitudinally through the cartilage rings diametrically opposite the smooth muscle. On one of these strips, the epithelium was removed by gently rubbing the luminal surface (over both the smooth muscle and the cartilage areas) with a cotton-wrapped metal rod. Small segments of trachea were mounted into 10-ml vertical organ baths (TSZ-04; Experimetria, Budapest, Hungary) containing Krebs solution (36°C) with the following composition: 118 mM NaCl, 4.7 mM KCl, 2.5 mM CaCl 2 , 1.0 mM NaH 2 PO 4 , 1.2 mM MgCl 2 , 24.9 mM NaHCO 3 , and 11.5 mM glucose, pH 7.4, gassed with a mixture of 95% O 2 and 5% CO 2 . All experiments were performed in the presence of 10 µM dipyridamole to inhibit membrane purine transport and to avoid the intracellular effects of adenosine. Tissues were mounted under an initial resting tension of 10 mN and left to equilibrate for a period of 90 min before the experimental protocol was started. Tension changes were recorded by using isometric force transducers (SG-01D, Experimetria) connected to a potentiometric recorder (SP-K2V; Riken Denshi, Tokyo).
Experiments were also carried out in a coaxial bioassay system with a slight modification of the methods described by Fernandes et al. (10) , Eglen et al. (11) , and Hay et al. (12) . This bioassay involved an epithelium-intact or denuded guinea-pig tracheal tube (donor tissue) and an epithelium-denuded tracheal strip (sensor strip). The tracheal tube was cut longitudinally and kept in a half-open state, using a special, polyethylene mini self-retaining retractor to avoid possible mechanical friction between the tracheal tube and the assay preparation and also to allow the more intensive diffusion of various substances into the lumen of the tube.
Experimental protocol
In all tracheal strip experiments, a concentrationresponse curve was recorded with increasing concentrations (0.1 -10 µM) of methacholine. The strips were washed every 10 min for 40 min, and then they were contracted with methacholine (0.3 µM, a concentration corresponding to the approximate half-maximum response) and left until a steady tone had developed.
Methacholine (0.3 µM) evoked an average 9 ± 3 (endothelium-intact, n = 23) and 11 ± 3 mN (endothelium-denuded, n = 23) contractile force in tracheal strips obtained from solvent (6 weeks)-treated guinea pigs. Chronic caffeine treatment (6 weeks) did not influence significantly the methacholine-induced contraction in either endothelium-intact or -denuded tracheal strips (12 ± 4 and 14 ± 4 mN, respectively; n = 21 in each group). It is noted that no statistical difference was observed in the 0.3 µM methacholine-induced contraction throughout the 10-week experimental period.
Cumulative concentration-response curves (E / [A]) were then obtained by adding adenosine, in threefold increments, to the organ baths. After a wash-out period, the tracheal strips were incubated with specific agents: indomethacin and diclofenac sodium (inhibitors of cyclooxygenase), nordihydroguaretic acid and AA861 (lipoxygenase inhibitors), cromolyn sodium (a blocker of mast cell degranulation), capsaicin (an agonist on vanilloid receptor subtype 1), N-carboxymethyl-Phe-Leu, phosphoramidon and thiorphan (inhibitors of neutral endopeptidase), and N ω -nitro-L-arginine (L-NOARG, an inhibitor of all nitric oxide synthase isoforms) for 50 min and the trachea was then recontracted with methacholine. Adenosine (E / [A]) curves were again recorded in this precontracted state. After the second adenosine (E/ [A]) curve had been completed, papaverine (100 µM) was added to the organ bath to determine the maximum relaxation of the tracheal specimens. The relaxation was expressed as a percentage of the maximum effect of 100 µM papaverine, the average value of which was 6 ± 3 mN below the resting tension.
In a separate series of experiments, in vitro capsaicin (20 µM) pretreatment and consecutive wash-outs were carried out to deplete capsaicin-sensitive neuropeptides according to the method described by Zygmunt et al. (13) .
Data analysis
An agonist-induced change in mechanical activity was expressed as a percentage reduction of the methacholine-induced precontraction. The papaverineinduced maximum effect was taken as 100% relaxation. Individual E / [A] curve data were fitted by means of the least-square iterative computer program Prism (GraphPad, San Diego, CA, USA) to a logistic function of the following form:
is the concentration of the agonist, EC 50 is the concentration producing the half-maximum response, and n H is the midpoint slope parameter. This function is generally used and accepted for the evaluation of concentrationresponse curves similar to ours, and its use was further justified by our results showing a good fit to our data with correlation coefficients between 0.86 and 0.98. The concentration ratio was calculated as the ratio of the EC 50 values for the adenosine-induced relaxation of solvent-and caffeine-treated tracheal tissues.
The data are expressed as means ± S.E.M. The EC 50 values are expressed throughout the text as their negative base 10 logarithms (pD 2 values). Multiple comparisons between the experimental groups were performed by one-way analysis of variance (ANOVA) with a Newman-Keuls post hoc test (see data of Tables 1 and 2 , as well as Figs. 1 and 2) . The one-sample t-test was used for determining the significance of the differences of concentration ratios from 1 (Tables 1 and 2) , whereas the paired t-test was applied in the case of appropriately matched pairs (Table 3 and 
Materials
Freshly prepared solutions of the following drugs were used: AA861, adenosine, caffeine, capsaicin, cromolyn sodium, diclofenac sodium, dipyridamole, indomethacin, methacholine chloride, L-NOARG, Ncarboxymethyl-Phe-Leu, nordihydroguaiaretic acid (NDGA), phosphoramidon, and thiorphan (all from Sigma, St. Louis, MO, USA).
Results

Effects of chronic caffeine treatment on body weight, mortality, and serum caffeine concentrations
The average increase in body weight of the guinea pigs that received caffeine did not differ significantly from the average increase in weight of the animals in the control group (2.5 ± 0.4 and 2.9 ± 0.5 g / day, respectively). No difference in mortality was found between the treated and control guinea pigs during the 10-week experiment (2.3% and 2.8%, respectively).
From day 3 of caffeine administration, equilibrium was established in the serum caffeine concentration, which subsequently remained constant throughout the 10-week study (39.1 ± 3.9 µM, n = 15). At 24 h after the withdrawal of the caffeine-containing solution, the average serum caffeine concentration was 2.3 ± 0.5 µM (n = 11). No caffeine was detected in sera obtained from solvent-treated animals (n = 12).
Adenosine-induced mechanical responses in epitheliumintact tracheal preparations during chronic caffeine treatment In isolated guinea-pig tracheal preparations precontracted with 0.3 µM methacholine, adenosine exerted a concentration-dependent (0.1 -100 µM) relaxant effect. During the 10-week treatment with caffeine-free solution, no significant differences were found in the pD 2 and E max values for adenosine (Table 1 ). On day 3 of caffeine treatment, the concentration-response curves for adenosine were slightly shifted to the left but without significant modification of the pD 2 and E max values ( Fig. 1a ). After treatment for 1 week, an approximately 5-fold leftward shift was observed, but without any influence on the maximum effects (Fig. 1b) . The sensitization to adenosine began to diminish from week 2 of treatment (a 3-fold leftward shift). As the caffeine treatment continued, the enhancement in the adenosineinduced relaxation disappeared at week 4, 6, and 10 ( Fig. 1: d , e, f).
Adenosine-induced mechanical responses in epitheliumdenuded tracheal preparations during chronic caffeine treatment
To test the potential role of the epithelium in the caffeine-induced changes in the adenosine sensitivity of the tracheal strips, experiments were also carried out on epithelium-denuded tracheal preparations. On day 3 of caffeine treatment, no difference was found between the adenosine-induced responses in the tracheal preparations obtained from the control and the caffeine-treated animals ( Fig. 2a ). From the 1st week, a significant (4-to 6-fold) leftward shift was observed in the responses of the tracheal strips from the caffeine-treated guinea pigs, throughout the remainder of the 10-week caffeine treatment ( Fig. 2 : b -f and Table 2 ). After a 2-week washout period, no significant difference in pD 2 was found between the tracheal strips obtained from the two treated groups (data not shown).
Study of the role of the epithelium in the reduction of adenosine-induced responses in a coaxial bioassay system
In the assay preparations (epithelium-free control tracheal strips), adenosine (3 µM) induced a 64 ± 5% relaxation (n = 5). When assay preparations were inserted coaxially into a control, epithelium-intact tracheal tube, a slight inhibition of the adenosine-induced relaxation was observed (55 ± 4%, n = 5, P<0.05; Fig. 3a ). The adenosine-sensitivity of the sensor strips (applied alone, without tracheal tube) did not differ significantly from that of the strips mounted inside the epitheliumdenuded tracheal tubes (64 ± 5% and 67 ± 6%, respec- tively, n = 5; Fig. 3b ).
In another series of experiments, the assay preparations were inserted into epithelium-intact tracheal tubes obtained from guinea pigs treated with caffeine for 6 weeks. In the sensor tracheal strips themselves, adenosine (3 µM) exerted a relaxation of 68 ± 5% (n = 6), but in the lumen of the caffeine (6 weeks)treated tracheal tubes, the adenosine-induced relaxation of the sensor strips was strongly reduced (25 ± 3% relaxation, n = 6, P<0.001; Fig. 3c ). When the epithelium was removed from the caffeine-treated tracheal preparations, no significant change was found in the responses to adenosine in the control, sensor strips (Fig. 3d ).
Influence of inhibitors of prostanoid and leukotriene synthesis on the epithelium-dependent bronchorelaxant responses to adenosine
Experiments were carried out on epithelium-intact tracheal strips obtained from guinea pigs treated with caffeine for 6 weeks. In the presence of 3 µM indomethacin (n = 4) or 20 µM diclofenac (n = 6), no modulation of the adenosine-induced relaxation was observed (not shown). Likewise, neither 20 µM NDGA (n = 4) nor 10 µM AA861 (n = 5) influenced the responses exerted by the purine nucleoside (not shown). It should be emphasized that in the forthcoming parts of the results, the relaxant actions of 3 µM adenosine (a concentration corresponding to the approximate EC 50 value) are compared, unless otherwise stated.
Effects of cromolyn, capsaicin pre-treatment, and inhibitors of neutral endopeptidase on the adenosineinduced relaxation in the chronically caffeine-treated trachea
Following the challenge to adenosine (3 µM), in vitro pretreatment with 20 µM cromolyn sodium was carried out in 5 epithelium-intact tracheal strips obtained from guinea pigs treated with caffeine for 6 weeks. Cromolyn treatment did not exert any effect on the action of adenosine (Fig. 4a ).
After pretreatment with 20 µM capsaicin, a significant enhancement (by 24 ± 3%) of the adenosine-induced relaxation was observed (from 58 ± 5% to 72 ± 4%, n = 4, P<0.05; Fig. 4b ). In the solvent-treated, control preparations, capsaicin pretreatment caused only a minor enhancement (by 10 ± 4%) of the adenosineinduced mechanical responses (not shown).
Following the complete development of the methacholine-induced contraction, we applied 1 µM capsaicin. Capsaicin induced a further contraction in the epithelium-intact, control tracheal preparations. In the presence of capsaicin, the 3 µM adenosine-induced relaxation was inhibited by 34 ± 3% (n = 5).
Tissues obtained from animals treated with caffeine for 6 weeks were incubated in the presence of 3 µM Ncarboxymethyl-Phe-Leu (n = 6) or 10 µM thiorphan (n = 5). Following exposure of the epithelium-intact tracheas to N-carboxymethyl-Phe-Leu (3 µM), the adenosine-induced relaxation was reduced by 66 ± 4% (n = 4, P<0.001; Fig. 4c ). The other inhibitor of neutral endopeptidase (thiorphan at 10 µM, n = 5) displayed similar action (suppression of adenosine-induced relaxation: 43 ± 5%). The inhibition of neutral endopeptidase by phosphoramidone (10 µM) also antagonized the responses evoked by the purine nucleoside (by 61 ± 5%, n = 4; Fig. 4d ). In the tracheal specimens from the timematched solvent-treated controls, the presence of Ncarboxymethyl-Phe-Leu (3 µM) or phosphoramidone (10 µM) exerted significantly less (24 ± 3% and 16 ± 4%, respectively) inhibition of the adenosineinduced decrease of methacholine-induced precontrac- Solvent-treated (epithelium-denuded) 60 ± 2 5 8 ± 4 6
Caffeine-treated (epithelium-intact) 59 ± 3 7 2 ± 4 a 5
Caffeine-treated (epithelium-denuded) 70 ± 1 7 6 ± 3 a 5
Data are the mean values ± S.E.M. a P<0.05, for the difference between the adenosine-induced relaxation before and after application of L-NOARG. Analysis of statistical significance was performed by the paired Student t-test.
tion (n = 4 in both cases, P<0.01).
Action of NOS (nitric oxide synthase) inhibition on the adenosine-induced relaxation
Pretreatment by 200 µM L-NOARG of solvent (6 weeks)-treated, epithelium-intact tracheal strips significantly reduced the adenosine (3 µM)-induced relaxation. In epithelium-denuded strips, the presence of 200 µM L-NOARG did not influence the action of adenosine. In epithelium-intact tracheal preparations from caffeine (6 weeks)-treated guinea pigs, in the presence of 200 µM L-NOARG, the adenosine-induced relaxation was profoundly enhanced. A slight potentiation in the adenosine action was also observed in epithelium-denuded tracheal strips obtained from caffeinetreated animals ( Table 3 ).
Discussion
This paper provides the first indication that longlasting and a relatively high-dose caffeine treatment, at least in guinea pigs, is able to induce a transient sensitization of the adenosine-induced tracheal relaxation. Caffeine, a widely consumed psychoactive drug, is thought to be a non-specific antagonist on adenosine receptors (14) . This methylxanthine exerts its antagonistic effect most potently on the A 2A receptors, less strongly on the A 1 and A 2B receptors, and only displays weak inhibitory action on the A 3 receptors (15). The guinea-pig trachea has been postulated to contain A 2 adenosine receptors (16 -18) , but Losinski and Alexander (19) have shown that isolated tracheal rings from guinea pigs exhibit a pharmacology inconsistent with either A 2A or A 2B adenosine receptors; the agonist profile of tracheal specimens is rather compatible with the presence of an A 2B adenosine receptor, whereas the antagonist profile is more similar to that of an A 2A adenosine receptor. It was therefore suggested that the tracheal adenosine receptor is a further subtype of the A 2 receptor, distinct from the A 2A and A 2B receptors, and can be considered a novel type of A 2 adenosine receptor. It should be noted that some experimental data indicate the existence of xanthine-insensitive sites for adenosine in the guinea-pig trachea, these sites probably having intracellular locations (16, 20) . To exclude the interactions of adenosine with these putative intracellular sites, we carried out the present experiments in the presence of an inhibitor of membrane adenosine transport.
The effects of chronic caffeine treatment on the adenosine receptors are controversial. Some studies on the central nervous system suggested an upregulation of the A 1 receptors (21, 22) but others indicated no upregulation after treatment with caffeine (23 -26) . Contrast-ing data have also been published on the regulation of the A 2 adenosine receptors during chronic caffeine treatment. In a number of experiments, caffeine administration was not found to be associated with an alteration in the number of A 2A adenosine receptors, whereas Johansson et al. (3) reported that caffeine ingestion (1 g / l) increased the number of A 2A receptors in the striatum of mouse brain. As far as the A 2B adenosinereceptor regulation is concerned, Fredholm (27) did not observe any alteration in the number of central A 2B receptors after a 1-week treatment with caffeine in rats.
Relatively few literature reports deal with the action of long-term caffeine administration on peripheral adenosine receptors. Varani et al. (6, 7) demonstrated that caffeine intake induces functional alterations and the upregulation of human platelet A 2A receptors. Zhang and Wells (4) described an increased number of A 2 adenosine receptors and A 2 -receptor-related biochemical changes in rat platelets after long-term caffeine treatment, but did not observe any modification in A 1receptor-induced lipolysis in fat cell membranes, although the number of A 1 receptors was significantly reduced. Concerning the cardiovascular implications of caffeine treatment, a 2-week caffeine treatment strongly potentiated the A 1 adenosine receptor-induced suppression of the sinoatrial rate, whereas the vasodilator and reflex tachycardic responses to an A 2A -receptor agonist were unchanged (28) .
No data are available, however, on the action of chronic methylxanthine treatment on the adenosine sensitivity of the bronchial system. Such examinations may be of importance from at least two aspects: a) adenosine can play an important regulatory role in the physiological functions of the respiratory system and has a significant pathogenetic role in bronchial asthma (8, 29) ; b) the frequent consumption of caffeine as an adenosine-receptor antagonist can theoretically modify the adenosinergic regulation of the bronchial system.
The average serum caffeine concentrations measured in our experiments (approx. 40 µM) are well over the conventional caffeine levels (1 -10 µM) observed after the moderate (2 -3 cups daily) consumption of coffee (see ref. 30 , for reviews). Therefore, our experimental conditions can represent an excessive coffee consumption rather than a normal intake if the data from animal experiments can be extrapolated to humans.
In our experiments, the continuous administration of caffeine as a non-specific adenosine-receptor antagonist led to an enhancement in the relaxation elicited by adenosine in epithelium-intact tracheal preparations from guinea pigs. The course of the sensitization process was unusual however: after an initial sensitization period (up to week 2), the adenosine-induced mechanical responses and the parameters of the E / [A] curves (pD 2 and E max values) returned to the control levels. Surprisingly, the epithelium-denuded tracheal preparations of the caffeine-treated guinea pigs did not exhibit such biphasic effects: continuous, clear-cut sensitization was observed throughout the 10-week treatment period. It seemed conceivable (and this was confirmed by the experiments with the co-axial bioassay system) that these differences could be due to an adaptogenic mechanism of the tracheal epithelium. The epithelium is known to be a rich source of various bronchodilator and bronchoconstrictor substances (31, 32) . It has been established that the airway epithelial cells express cyclooxygenase and 5-lipoxygenase. A significant basal release of PGF 2α (33) has been demonstrated from the respiratory epithelial cells of guinea pigs, and leukotrienes can also be synthesized in the epithelial cells (see ref. 31 for a review). It has been reported that the granules of the guinea pig and the rat tracheal epithelium display calcitonin gene-related peptide (CGRP) immunoreactivity, and capsaicin treatment reduces the staining of these cells for CGRP (34 -36) .
Besides CGRP, endothelin-like immunoreactivity has also been localized to the airway epithelium (see ref. 31 for a review), and endothelin release from the guinea-pig tracheal epithelium has been determined (37) .
As indomethacin and diclofenac (inhibitors of cyclooxygenase) and NDGA and AA861 (a non-selective and a selective inhibitor of lipoxygenase, respectively) did not influence the relaxation evoked by adenosine, the adenosine-induced release of bronchoconstrictor prostanoids and leukotrienes could be excluded. An enhanced release of mast cell-derived constrictor agents was also unlikely, as in the presence of cromolyn (a "mast cell stabilizer") the adenosine-induced tracheal responses were also unaffected.
Our results with the use of capsaicin and inhibitors of neutral endopeptidase (a membrane-bound enzyme responsible for terminating the actions of tachykinins and other bioactive peptides) as pharmacological tools suggest that after a long-term caffeine treatment, the amounts of the epithelial bronchoconstrictor peptides are increased. Capsaicin has been thought to deplete the neuropeptides not only from the sensory nerve fibres (38, 39) , but also from the airway epithelial cells (34) . Our present findings that the depletion of neuropeptides by capsaicin pretreatment increases the adenosineinduced relaxation and that the liberation of neuropeptides in the presence of capsaicin inhibits the action of the purine nucleoside provided pharmacological proof that continuous treatment with caffeine leads to an adaptive response of the tracheal epithelial cells that counterbalances the actions of adenosine. Moreover, we have established that the relaxant property of adenosine is strongly inhibited in the presence of inhibitors of neutral endopeptidase (phosphoramidone, thiorphan, and N-carboxymethyl-Phe-Leu), indicating the increased involvement of bronchoconstrictor peptides of epithelial origin (e.g., CGRP), though the role of non-epithelial cells can not be entirely excluded. Although no direct measurements have been performed in the present study, on the basis of the pharmacological approach, it could be suggested that besides some neuropeptides, an increased production of endothelin might also play a role in the caffeine-induced adaptation process. Both thiorphan and phosphoramidone, at the concentration applied (10 µM), have been reported to increase the release of immunoreactive endothelin and the constrictor action of endothelin in the guinea-pig trachea (40, 41) . Our assumptions are in concert with the results of the in vivo experiments of Kohno et al. (42) : the plasma level of immunoreactive endothelin was increased in rats after 6 weeks of caffeine administration.
In addition, it should be taken into account that some changes in the nitric oxide synthase-NO system can play a significant role in the adenosine-induced relaxation. Our findings on tracheal strips from solvent treated animals are in good accordance with the results of Ali et al. (43) , in rabbit airway smooth muscle, according to which inhibition of NOS inhibited the adenosinereceptor-mediated relaxation. Surprisingly, in our studies on tracheal strips obtained from caffeine-treated guinea pigs, inhibition of NOS did not reduce, but profoundly enhanced the adenosine-induced decrease of the methacholine-induced precontraction. Very recently, it has been described that acute administration of caffeine decreases NOS expression in rat skeletal muscles (44) , but no literature data are available for the action of caffeine during long-lasting treatment. On the basis of our results, NO appears to be a constrictor in long-term caffeine-treated specimens and this could explain, at least in part, the observed phenomenon. Further extensive studies are necessary, of course, for elucidating these paradoxic findings. At any rate, it seems conceivable that chronic caffeine treatment induces a complex modulation in the action of epithelium-derived contraction-and relaxation-inducing substances.
In summary, our results demonstrate that the continuous administration of a relatively high dose of caffeine to guinea pigs gives rise to an unusual, biphasic modulation of the adenosine-related tracheal responses. It may be supposed that the gradual loss of caffeine-induced hypersensitivity in the adenosine-induced relaxation is due to the counterbalancing effect of the increased production of bronchoactive substances in the epithelial cells. In addition, it can also be suggested that during long-lasting caffeine-treatment NO operated as a bronchoconstrictor agent. It is noted that the results of these experiments, of course, can not automatically be extrapolated to the human respiratory system. However, on the basis of these findings, it is supposed that excessive coffee consumption might induce epithelium-dependent alterations in the adenosine-receptor-mediated regulation of bronchial responses, but the clinical relevance of this phenomenon remains to be determined.
